A Phase I and Pilot Study of the Effect of rhIL-7-hyFc (NT-I7) on CD4 Counts in Patients with High Grade Gliomas and Severe Treatment-Related CD4 Lymphopenia after Concurrent Radiation and Temozolomide

Grant

Date/time Interval

  • May 1, 2018 - April 30, 2020
  • Total Award Amount

  • 6000.00
  • Direct Costs

  • 4040.00
  • Sponsor Award Id

  • ABTC 1403
  • Contributor

  • Fathallah-Shaykh M.D., Ph.D., Hassan   Investigator  
  • Han, Xiaosi   Investigator  
  • Lobbous, Mina   Investigator  
  • Nabors M.D., Louis   Principal Investigator